Hepatic Hemodynamic Changes and Simulation in Living-Related Liver Transplantation

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by National Taiwan University Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT00234624
First received: October 5, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
  Purpose

This 1-year project is intended to study the hemodynamic changes of poratal and hepatic artery during living related liver transplantation. We hypothesize that after right hepatectomy for living related liver transplatation, portal vein overflow will change the remnant liver contour and result in liver hyperplasia.


Condition
Right Hepatectomy

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Longitudinal
Official Title: Hepatic Hemodynamic Changes and Simulation Before /After Living-Related Liver Transplantation in Donors/Recipients

Resource links provided by NLM:


Further study details as provided by National Taiwan University Hospital:

Estimated Enrollment: 10
Study Start Date: September 2005
Detailed Description:

We use CT as tools to reconstruct 3D images of portal vein and hepatic artery before and one month after operation. The images are transferred to CAD and computer simulation is performed.

  Eligibility

Ages Eligible for Study:   21 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria: - Informed adult-to adult living donor underwent right lobectomy

Exclusion Criteria:

  • no written informed contents
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00234624

Contacts
Contact: Cheng-Maw Ho, MD +886-2-23123456 ext 9801914 miningho@ntu.edu.tw
Contact: Po-Huang Lee, PhD

Locations
Taiwan
NTUH Recruiting
Taipei, Taiwan, 100
Contact: Cheng-Maw Ho, MD    +886-2-23123456 ext 9801914    miningho@ntu.edu.tw   
Contact: Po-Huang Lee, PhD    +886-2-23123456 ext 5104    pohuang@ha.mc.ntu.edu.tw   
Sub-Investigator: Cheng-Maw Ho, MD         
Principal Investigator: Po-Huang Lee, PhD         
Sponsors and Collaborators
National Taiwan University Hospital
Investigators
Principal Investigator: Po-Huang Lee, PhD NTUH
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00234624     History of Changes
Other Study ID Numbers: 9461700821
Study First Received: October 5, 2005
Last Updated: October 5, 2005
Health Authority: Taiwan: Department of Health

ClinicalTrials.gov processed this record on September 30, 2014